Benign multiple sclerosis and long-term outcomes after 30 years

dc.contributor.authorMatas, Elisabet
dc.contributor.authorBau, Laura
dc.contributor.authorRomero Pinel, Lucía María
dc.contributor.authorLeón, Isabel
dc.contributor.authorArroyo Pereiro, Pablo
dc.contributor.authorMuñoz Vendrell, Albert
dc.contributor.authorMartínez Yélamos, Antonio
dc.contributor.authorMartínez Yélamos, Sergio
dc.date.accessioned2025-11-27T13:54:16Z
dc.date.available2025-11-27T13:54:16Z
dc.date.issued2025-11-01
dc.date.updated2025-11-27T11:28:18Z
dc.description.abstractBackground The concept of benign multiple sclerosis (MS) is a matter of debate. In most definitions, only the Expanded Disability Status Scale (EDSS) score and disease duration are considered, although other factors may influence a patient's disability. The aims of this study were to evaluate the percentage of patients with benign MS in our cohort and to determine the proportion of these patients who remained benign after 20 and 30 years of disease evolution. Clinical and demographic variables related to this outcome were investigated. Methods Patients fulfilling the criteria for benign MS (EDSS < 3.0 and at least 10 years of MS evolution) were selected from a hospital-based series and followed up prospectively. The EDSS was assessed after 20 and 30 years of MS evolution. Clinical and radiological variables were evaluated. Fatigue, depression and cognition tests were performed. Results Eighty-two of the 485 patients evaluated in 1996 fulfilled the criteria for benign MS and were selected. In 51 of the 68 (75%) patients evaluated in 2006, the EDSS score continued to be <= 3. In 2016, 35 out of 58 (60%) patients continued to have an EDSS score <= 3. None of the clinical variables could predict persistence in the benign group. Eighteen of the 35 benign MS patients completed the questionnaires after 30 years. Fifty percent of them reported fatigue, 22% depression, and 83% had cognitive impairment. Conclusion The majority of MS patients maintained a benign status even after 30 years of disease evolution. However, cognitive impairment in this group is notable.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1432-1459
dc.identifier.pmid41191123
dc.identifier.urihttps://hdl.handle.net/2445/224460
dc.language.isoeng
dc.publisherSpringer Science and Business Media LLC
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1007/s00415-025-13402-8
dc.relation.ispartofJournal of Neurology, 2025, vol. 272, 747
dc.relation.urihttps://doi.org/10.1007/s00415-025-13402-8
dc.rightscc-by (c) Matas, Elisabet et al., 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.classificationMalalties del sistema nerviós central
dc.subject.classificationMalalties cerebrals
dc.subject.classificationEsclerosi múltiple
dc.subject.otherCentral nervous system diseases
dc.subject.otherBrain diseases
dc.subject.otherMultiple sclerosis
dc.titleBenign multiple sclerosis and long-term outcomes after 30 years
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
s00415-025-13402-8.pdf
Mida:
637.56 KB
Format:
Adobe Portable Document Format